| Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers (NCT05296564) | Hadassah Medical Organization | 2022-04-01 |
| Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas (NCT04248959) | University Health Network, Toronto | 2022-02-02 |
| A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma (NCT05193214) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2022-01-25 |
| Analysis of the Molecular Profile of the Mixofibrosarcoma of the Extremities (NCT04991883) | Istituto Ortopedico Rizzoli | 2021-09-01 |
| Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma （SPARE-02） (NCT05235100) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-09-01 |
| Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus (NCT05614375) | Eye & ENT Hospital of Fudan University | 2021-06-12 |
| Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases (NCT04887298) | Moleculin Biotech, Inc. | 2021-06-05 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors (NCT04673942) | EpicentRx, Inc. | 2021-03-29 |
| Pemetrexed, Cisplatin With Soft Tissue Sarcoma (NCT04605770) | Yonsei University | 2020-12-22 |
| Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma (NCT04910126) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2020-11-12 |
| Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma (NCT04577014) | Memorial Sloan Kettering Cancer Center | 2020-09-29 |
| Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma (NCT04595994) | Grupo Espanol de Investigacion en Sarcomas | 2020-09-02 |
| Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01） (NCT05167994) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2020-05-01 |
| Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma (NCT04172805) | Sun Yat-sen University | 2020-03-13 |
| MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma (NCT04216953) | Centre Leon Berard | 2020-02-12 |
| Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction (NCT04347122) | University of Kansas Medical Center | 2020-01-28 |
| Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion (NCT04219202) | University Hospital Heidelberg | 2019-05-09 |
| Metabolic Characteristics of Sarcoma In Vivo Using HP 13-C Magnetic Resonance Spectroscopic Imaging (MRSI) (NCT03759704) | University of Texas Southwestern Medical Center | 2019-01-01 |
| GISAR German Interdisciplinary Sarcoma Registry (NCT04122872) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2018-11-29 |
| Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients (NCT03985722) | Grupo Espanol de Investigacion en Sarcomas | 2018-09-21 |
| Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy (NCT03474094) | Centre Leon Berard | 2018-08-01 |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas (NCT03600649) | Salarius Pharmaceuticals, LLC | 2018-06-04 |
| Trabectedin Maintenance Post 1st-line in STS (NCT02929394) | European Organisation for Research and Treatment of Cancer - EORTC | 2017-11-07 |
| Radiomics for Tumor Grading of Soft Tissue Sarcomas. (NCT03798795) | Technical University of Munich | 2017-10-01 |
| Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma (NCT02808247) | European Organisation for Research and Treatment of Cancer - EORTC | 2017-07-07 |
| Low-dose Computer Tomography in Follow-up of Soft Tissue Sarcomas (NCT05813808) | Helsinki University Central Hospital | 2017-06-01 |
| Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma (NCT02897128) | The Cleveland Clinic | 2016-07-01 |
| Retrospective Study of Trabectedin in Soft Tissue Sarcomas (NCT02793050) | Italian Sarcoma Group | 2016-06-15 |
| A Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas (NCT03058406) | Eisai Co., Ltd. | 2016-03-01 |
| Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma (NCT02584309) | Washington University School of Medicine | 2016-02-22 |
| Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery (NCT02464332) | Blaze Bioscience Inc. | 2015-09-01 |
| A Study to Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue Sarcomas (NCT02994264) | Institut de Cancérologie de Lorraine | 2015-08-01 |
| Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas (NCT02415816) | St. Jude Children's Research Hospital | 2015-06-05 |
| Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma (NCT02367651) | GlaxoSmithKline | 2015-06-01 |
| Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy (NCT02300545) | Washington University School of Medicine | 2015-04-08 |
| Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment (NCT02812654) | AC Camargo Cancer Center | 2015-03-01 |
| A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma (NCT02326025) | Eli Lilly and Company | 2015-01-22 |
| Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study (NCT02309242) | Universitaire Ziekenhuizen KU Leuven | 2014-12-01 |
| Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients (NCT02275286) | Grupo Espanol de Investigacion en Sarcomas | 2014-11-01 |
| Long Term Morbidity and Quality of Life in Retroperitoneal Sarcomas (NCT03480399) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-01-01 |
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors (NCT01962103) | Celgene | 2013-12-04 |
| Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS (NCT01995981) | Radboud University Medical Center | 2013-12-01 |
| (SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas (NCT01949506) | Medical College of Wisconsin | 2013-09-24 |
| Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma (NCT01543802) | Heidelberg University | 2013-04-01 |
| Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia (NCT01491594) | Duke University | 2012-04-01 |
| A Study of Olaratumab in Soft Tissue Sarcoma (NCT01185964) | Eli Lilly and Company | 2010-10-01 |
| Combined Modality Treatment of Sarcomas of the Extremities (NCT01985295) | The Netherlands Cancer Institute | 2010-06-01 |
| Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy (NCT00753688) | GlaxoSmithKline | 2008-10-01 |
| A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma (NCT00490451) | Eli Lilly and Company | 2007-08-01 |
| Sunitinib in Certain Subtypes of Soft Tissue Sarcomas (NCT00859456) | Columbia University | 2007-04-01 |
| BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas (NCT00406601) | Istituto Clinico Humanitas | 2006-11-01 |
| TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients (NCT00289809) | Istituto Clinico Humanitas | 2006-09-01 |
| Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis (NCT00243685) | Pierian Biosciences | 2006-09-01 |
| Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma (NCT00297258) | GlaxoSmithKline | 2005-11-01 |
| Alimta Plus Gemcitabine for Advanced Sarcoma (NCT00860015) | Columbia University | 2005-08-01 |
| a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4 (NCT00130858) | Cooperative Weichteilsarkom Study Group | 2005-01-01 |
| Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors (NCT00187174) | St. Jude Children's Research Hospital | 2004-10-01 |
| Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) (NCT00093080) | Merck Sharp & Dohme LLC | 2004-10-01 |
| Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) (NCT00204568) | University Hospital Schleswig-Holstein | 2004-08-01 |
| Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma (NCT00079950) | Enzon Pharmaceuticals, Inc. | 2003-08-01 |
| Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma (NCT00061659) | Abbott | 2003-05-01 |
| Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas (NCT00134641) | Dana-Farber Cancer Institute | 2003-02-01 |
| Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma (NCT00142571) | Memorial Sloan Kettering Cancer Center | 2003-01-01 |
| Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS) (NCT00204620) | University Hospital Tuebingen | 2002-03-01 |
| Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) (NCT00204646) | University Hospital Tuebingen | 1999-02-01 |
| Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial) (NCT05612191) | Advenchen Laboratories, LLC | |